vs
徕博科（LH）与RPM INTERNATIONAL INC（RPM）财务数据对比。点击上方公司名可切换其他公司
徕博科的季度营收约是RPM INTERNATIONAL INC的1.8倍（$3.5B vs $1.9B），RPM INTERNATIONAL INC净利率更高（8.4% vs 4.7%，领先3.8%），徕博科同比增速更快（5.6% vs 3.5%），徕博科自由现金流更多（$490.3M vs $296.4M），过去两年RPM INTERNATIONAL INC的营收复合增速更高（12.0% vs 5.2%）
徕博科（Labcorp）是全球领先的生命科学与诊断检测企业，面向医疗机构、制药企业和个人患者提供全面的临床检验服务、药物研发支持及医疗检测解决方案，依托先进科研经验与创新技术输出准确可落地的健康洞察，助力临床决策、加快新药研发，提升全球患者健康水平。
BVS娱乐前身为Saban制作、Saban国际及Saban娱乐，是华特迪士尼公司旗下子公司。1980年4月24日由哈伊姆·萨班与舒基·利维创立，最初主营音乐制作，后逐步转向电视节目制作发行业务，最为知名的是为Fox Family/ABC Family及已停播的Fox Kids、Jetix频道制作发行儿童节目。
LH vs RPM — 直观对比
营收规模更大
LH
是对方的1.8倍
$1.9B
营收增速更快
LH
高出2.1%
3.5%
净利率更高
RPM
高出3.8%
4.7%
自由现金流更多
LH
多$193.9M
$296.4M
两年增速更快
RPM
近两年复合增速
5.2%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.5B | $1.9B |
| 净利润 | $164.7M | $161.2M |
| 毛利率 | 28.2% | 40.8% |
| 营业利润率 | 7.6% | 11.0% |
| 净利率 | 4.7% | 8.4% |
| 营收同比 | 5.6% | 3.5% |
| 净利润同比 | 14.9% | -12.0% |
| 每股收益（稀释后） | $1.98 | $1.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LHRPM
| Q4 25 | $3.5B | $1.9B | ||
| Q3 25 | $3.6B | $2.1B | ||
| Q2 25 | $3.5B | $2.1B | ||
| Q1 25 | $3.3B | $1.5B | ||
| Q4 24 | $3.3B | $1.8B | ||
| Q3 24 | $3.3B | $2.0B | ||
| Q2 24 | $3.2B | $2.0B | ||
| Q1 24 | $3.2B | $1.5B |
净利润LHRPM
| Q4 25 | $164.7M | $161.2M | ||
| Q3 25 | $261.1M | $227.6M | ||
| Q2 25 | $237.9M | $225.8M | ||
| Q1 25 | $212.8M | $52.0M | ||
| Q4 24 | $143.4M | $183.2M | ||
| Q3 24 | $169.3M | $227.7M | ||
| Q2 24 | $205.3M | $180.6M | ||
| Q1 24 | $228.0M | $61.2M |
毛利率LHRPM
| Q4 25 | 28.2% | 40.8% | ||
| Q3 25 | 28.8% | 42.3% | ||
| Q2 25 | 29.7% | 42.4% | ||
| Q1 25 | 28.3% | 38.4% | ||
| Q4 24 | 26.9% | 41.4% | ||
| Q3 24 | 27.6% | 42.5% | ||
| Q2 24 | 28.8% | 41.4% | ||
| Q1 24 | 28.2% | 39.9% |
营业利润率LHRPM
| Q4 25 | 7.6% | 11.0% | ||
| Q3 25 | 11.1% | 14.1% | ||
| Q2 25 | 11.2% | 11.9% | ||
| Q1 25 | 9.7% | 2.8% | ||
| Q4 24 | 6.5% | 11.5% | ||
| Q3 24 | 7.7% | 14.8% | ||
| Q2 24 | 9.2% | 11.9% | ||
| Q1 24 | 10.1% | 5.5% |
净利率LHRPM
| Q4 25 | 4.7% | 8.4% | ||
| Q3 25 | 7.3% | 10.8% | ||
| Q2 25 | 6.7% | 10.8% | ||
| Q1 25 | 6.4% | 3.5% | ||
| Q4 24 | 4.3% | 9.9% | ||
| Q3 24 | 5.2% | 11.6% | ||
| Q2 24 | 6.4% | 9.0% | ||
| Q1 24 | 7.2% | 4.0% |
每股收益（稀释后）LHRPM
| Q4 25 | $1.98 | $1.26 | ||
| Q3 25 | $3.12 | $1.77 | ||
| Q2 25 | $2.84 | $1.76 | ||
| Q1 25 | $2.52 | $0.40 | ||
| Q4 24 | $1.72 | $1.42 | ||
| Q3 24 | $2.00 | $1.77 | ||
| Q2 24 | $2.43 | $1.40 | ||
| Q1 24 | $2.69 | $0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $532.3M | $316.6M |
| 总债务越低越好 | — | $2.5B |
| 股东权益账面价值 | $8.6B | $3.1B |
| 总资产 | $18.4B | $7.9B |
| 负债/权益比越低杠杆越低 | — | 0.80× |
8季度趋势，按日历期对齐
现金及短期投资LHRPM
| Q4 25 | $532.3M | $316.6M | ||
| Q3 25 | $598.1M | $297.1M | ||
| Q2 25 | $647.3M | $302.1M | ||
| Q1 25 | $369.4M | $241.9M | ||
| Q4 24 | $1.5B | $268.7M | ||
| Q3 24 | $1.5B | $231.6M | ||
| Q2 24 | $265.1M | $237.4M | ||
| Q1 24 | $99.3M | $248.9M |
总债务LHRPM
| Q4 25 | — | $2.5B | ||
| Q3 25 | — | $2.7B | ||
| Q2 25 | — | $2.6B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $2.2B |
股东权益LHRPM
| Q4 25 | $8.6B | $3.1B | ||
| Q3 25 | $8.7B | $3.1B | ||
| Q2 25 | $8.5B | $2.9B | ||
| Q1 25 | $8.3B | $2.7B | ||
| Q4 24 | $8.1B | $2.7B | ||
| Q3 24 | $8.2B | $2.6B | ||
| Q2 24 | $8.0B | $2.5B | ||
| Q1 24 | $8.0B | $2.3B |
总资产LHRPM
| Q4 25 | $18.4B | $7.9B | ||
| Q3 25 | $18.3B | $7.9B | ||
| Q2 25 | $18.1B | $7.8B | ||
| Q1 25 | $17.6B | $6.6B | ||
| Q4 24 | $18.4B | $6.7B | ||
| Q3 24 | $18.6B | $6.6B | ||
| Q2 24 | $16.7B | $6.6B | ||
| Q1 24 | $16.5B | $6.4B |
负债/权益比LHRPM
| Q4 25 | — | 0.80× | ||
| Q3 25 | — | 0.87× | ||
| Q2 25 | — | 0.91× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.77× | ||
| Q2 24 | — | 0.79× | ||
| Q1 24 | — | 0.93× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $614.2M | $345.7M |
| 自由现金流经营现金流 - 资本支出 | $490.3M | $296.4M |
| 自由现金流率自由现金流/营收 | 13.9% | 15.5% |
| 资本支出强度资本支出/营收 | 3.5% | 2.6% |
| 现金转化率经营现金流/净利润 | 3.73× | 2.14× |
| 过去12个月自由现金流最近4个季度 | $1.2B | $582.9M |
8季度趋势，按日历期对齐
经营现金流LHRPM
| Q4 25 | $614.2M | $345.7M | ||
| Q3 25 | $387.2M | $237.5M | ||
| Q2 25 | $620.6M | $149.2M | ||
| Q1 25 | $18.5M | $91.5M | ||
| Q4 24 | $777.2M | $279.4M | ||
| Q3 24 | $277.3M | $248.1M | ||
| Q2 24 | $561.1M | $181.2M | ||
| Q1 24 | $-29.8M | $173.4M |
自由现金流LHRPM
| Q4 25 | $490.3M | $296.4M | ||
| Q3 25 | $280.5M | $175.0M | ||
| Q2 25 | $542.7M | $78.2M | ||
| Q1 25 | $-107.5M | $33.3M | ||
| Q4 24 | $665.1M | $229.5M | ||
| Q3 24 | $161.5M | $197.3M | ||
| Q2 24 | $432.9M | $105.3M | ||
| Q1 24 | $-163.6M | $124.6M |
自由现金流率LHRPM
| Q4 25 | 13.9% | 15.5% | ||
| Q3 25 | 7.9% | 8.3% | ||
| Q2 25 | 15.4% | 3.8% | ||
| Q1 25 | -3.2% | 2.3% | ||
| Q4 24 | 20.0% | 12.4% | ||
| Q3 24 | 4.9% | 10.0% | ||
| Q2 24 | 13.4% | 5.2% | ||
| Q1 24 | -5.2% | 8.2% |
资本支出强度LHRPM
| Q4 25 | 3.5% | 2.6% | ||
| Q3 25 | 3.0% | 3.0% | ||
| Q2 25 | 2.2% | 3.4% | ||
| Q1 25 | 3.8% | 3.9% | ||
| Q4 24 | 3.4% | 2.7% | ||
| Q3 24 | 3.5% | 2.6% | ||
| Q2 24 | 4.0% | 3.8% | ||
| Q1 24 | 4.2% | 3.2% |
现金转化率LHRPM
| Q4 25 | 3.73× | 2.14× | ||
| Q3 25 | 1.48× | 1.04× | ||
| Q2 25 | 2.61× | 0.66× | ||
| Q1 25 | 0.09× | 1.76× | ||
| Q4 24 | 5.42× | 1.53× | ||
| Q3 24 | 1.64× | 1.09× | ||
| Q2 24 | 2.73× | 1.00× | ||
| Q1 24 | -0.13× | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LH
| Diagnostics | $2.7B | 78% |
| Biopharma Laboratory Services | $793.0M | 23% |
RPM
| Construction Products Group Segment | $737.4M | 39% |
| Consumer Segment | $638.6M | 33% |
| Performance Coatings Group Segment | $533.8M | 28% |
